186 related articles for article (PubMed ID: 26070560)
1. DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells.
Tian HP; Lun SM; Huang HJ; He R; Kong PZ; Wang QS; Li XQ; Feng YM
J Biol Chem; 2015 Jul; 290(31):19173-83. PubMed ID: 26070560
[TBL] [Abstract][Full Text] [Related]
2. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
[TBL] [Abstract][Full Text] [Related]
3. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
[TBL] [Abstract][Full Text] [Related]
4. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
Lo PK; Lee JS; Liang X; Sukumar S
Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
[TBL] [Abstract][Full Text] [Related]
5. Dual function of MAZ mediated by FOXF2 in basal-like breast cancer: Promotion of proliferation and suppression of progression.
Yu ZH; Lun SM; He R; Tian HP; Huang HJ; Wang QS; Li XQ; Feng YM
Cancer Lett; 2017 Aug; 402():142-152. PubMed ID: 28577976
[TBL] [Abstract][Full Text] [Related]
6. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.
Kang LJ; Yu ZH; Cai J; He R; Lu JT; Hou C; Wang QS; Li XQ; Zhang R; Feng YM
FASEB J; 2019 May; 33(5):6564-6573. PubMed ID: 30807702
[TBL] [Abstract][Full Text] [Related]
8. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J
Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064
[TBL] [Abstract][Full Text] [Related]
9. FOXF2 deficiency accelerates the visceral metastasis of basal-like breast cancer by unrestrictedly increasing TGF-β and miR-182-5p.
Lu JT; Tan CC; Wu XR; He R; Zhang X; Wang QS; Li XQ; Zhang R; Feng YM
Cell Death Differ; 2020 Oct; 27(10):2973-2987. PubMed ID: 32424142
[TBL] [Abstract][Full Text] [Related]
10. FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway.
Zhang X; Zhang R; Hou C; He R; Wang QS; Zhou TH; Li XQ; Zhai QL; Feng YM
J Biol Chem; 2022 Jul; 298(7):102082. PubMed ID: 35660418
[TBL] [Abstract][Full Text] [Related]
11. The controversial role of forkhead box F2 (FOXF2) transcription factor in breast cancer.
Lo PK
PRAS Open; 2017; 1():. PubMed ID: 29046905
[TBL] [Abstract][Full Text] [Related]
12. MiR-200c inhibits metastasis of breast tumor via the downregulation of Foxf2.
Zhang T; Wan JG; Liu JB; Deng M
Genet Mol Res; 2017 Aug; 16(3):. PubMed ID: 28829888
[TBL] [Abstract][Full Text] [Related]
13. Decreased FOXF2 mRNA expression indicates early-onset metastasis and poor prognosis for breast cancer patients with histological grade II tumor.
Kong PZ; Yang F; Li L; Li XQ; Feng YM
PLoS One; 2013; 8(4):e61591. PubMed ID: 23620774
[TBL] [Abstract][Full Text] [Related]
14. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
[TBL] [Abstract][Full Text] [Related]
15. FOXF2 deficiency permits basal-like breast cancer cells to form lymphangiogenic mimicry by enhancing the response of VEGF-C/VEGFR3 signaling pathway.
Wang QS; He R; Yang F; Kang LJ; Li XQ; Fu L; Sun B; Feng YM
Cancer Lett; 2018 Apr; 420():116-126. PubMed ID: 29409810
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer.
Shin JE; Park SH; Jang YK
Mol Cells; 2011 Feb; 31(2):181-9. PubMed ID: 21191816
[TBL] [Abstract][Full Text] [Related]
17. Role of transcription factor Sp1 and CpG methylation on the regulation of the human podocalyxin gene promoter.
Butta N; Larrucea S; Alonso S; Rodriguez RB; Arias-Salgado EG; Ayuso MS; González-Manchón C; Parrilla R
BMC Mol Biol; 2006 May; 7():17. PubMed ID: 16684343
[TBL] [Abstract][Full Text] [Related]
18. FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.
Chen X; Hu H; Liu J; Yang Y; Liu G; Ying X; Chen Y; Li B; Ye C; Wu D; Duan S
Tumour Biol; 2017 Feb; 39(2):1010428317692230. PubMed ID: 28222662
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
20. Sp1 is necessary for gene activation of Adamts17 by estrogen.
Jia Z; Gao S; M'Rabet N; De Geyter C; Zhang H
J Cell Biochem; 2014 Oct; 115(10):1829-39. PubMed ID: 24906090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
